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The evolutionary and lineage relationships between various stromal cell types that support the immune
system are not well understood. Recently, in Immunity, Castagnaro et al. (2013) identifiedmultipotentmesen-
chymal precursors that specifically give rise to stromal cell types in the spleen, but not other lymphoid tissue,
and support injury-induced regeneration.Multicellular organisms are constantly
confronted with parasites and have there-
fore evolved complex immune systems to
cope with this threat. In mammals, the
spleen, lymph nodes, and gut-associated
lymphoid structures play a central role in
the struggle against infections by facili-
tating efficient immune responses (Muel-
ler and Germain, 2009). Lymphoid tissues
possess a unique cellular composition of
immobile stromal cells and highly motile
hematopoietic cells such as lymphocytes
and dendritic cells; precisely regulated
mechanisms ensure that all cells receive
and respond to various types of signals
regulating their differentiation, interaction,
activation, and survival in steady-state
and inflammatory conditions. Tradition-
ally, hematopoietic cells have attracted
the most attention. However, the stromal
compartment also assumes an important
role in maintaining spleen populations
during homeostasis and in response to
injury, thus prompting Castagnaro and
colleagues (Castagnaro et al., 2013) to
examine the developmental origin andregenerative capacity of stromal cells in
the spleen.
The spleen belongs to the diverse
group of so-called secondary lymphoid
organs whose chief role is the regulation
of immune responses. (By contrast, pri-
mary lymphoid organs—bone marrow
and thymus—fulfill the task of supporting
the generation of the many different kinds
of immune effector cells.) Like other sec-
ondary lymphoid organs, the mature
spleen contains several types of stromal
cells (Figure 1). Previous studies had
failed to provide conclusive evidence
regarding the possible developmental
relationship of these cell types; it was
also unknown whether these different
stromal components shared a common
embryological origin or whether they
were capable of regenerating the stroma
after injury.
In order to examine these questions,
Castagnaro et al. turned to previous
embryological studies indicating that the
mesenchymal primordium of the spleen
(Landsman et al., 2011) expresses thetranscription factor gene Isl1 (Ahlgren
et al., 1997). Several other transcription
factor genes, including Nkx2.5, are also
expressed in the anlage of the spleen and
are important for its proper development
(Brendolan et al., 2007; Koss et al., 2012).
Based on these observations, Castag-
naro et al. carried out two parallel genetic
lineage tracing experiments using the
Cre/loxP system to indelibly mark cells
possessing a history of transcription fac-
tor gene expression. They made the
surprising observation that all types of
stromal cells in the spleen, with the
exception of endothelial cells, are de-
scendants of mesenchymal precursors
that at some stage had expressed either
Nkx2.5 or Isl1. Because Nkx2.5 and Isl1
proteins are coexpressed in mesen-
chymal cells at early stages of develop-
ment, the authors suggest that the com-
mon precursor of splenic stroma is
positive for both Nkx2.5 and Isl1 expres-
sion. At least four morphologically and
functionally distinguishable cell types
were derived from themultipotent stromalll 12, May 2, 2013 ª2013 Elsevier Inc. 501
Figure 1. Mesenchymal Progenitors Generate the Stromal Subsets
of Secondary Lymphoid Organs
Mesenchymal progenitors are induced to generate multipotent stromal pre-
cursors and lymphoid tissue organizer (LTo) cells, which may be one and the
same. It is unknown whether inductive signals are specific for distinct regions
of the developing embryo; also unknown is whether multipotent stromal
precursors and/or LTo possess the capacity for self-renewal. According to
Castagnaro et al. (2013), at least four morphologically and functionally distin-
guishable cells types are derived from the multipotent stromal precursors in
the spleen: fibroblastic reticular cells (FRCs), follicular dendritic cells (FDCs),
marginal reticular cells (MRCs), and perivascular cells (Peri) (see text for de-
tails). By contrast, endothelial cells of the vasculature have a different develop-
mental origin.
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Previewsprecursors (Figure 1) in-
cluding (1) fibroblastic retic-
ular cells, which are primarily
associated with clusters of
T cells and support the forma-
tion of a conduit network that
facilitates the directed migra-
tion of hematopoietic cells; (2)
follicular dendritic cells,
which associate with aggre-
gates of B cells, capture and
present antigens, and are
instrumental in supporting
theprocessof affinitymatura-
tion bywhich strongly binding
antibodies are produced dur-
ing an immune response; (3)
marginal reticular cells, which
provide structural support
and also participate in
conduit formation; and (4)
perivascular cells, which en-
sheath the vasculature.
Castagnaro et al. pro-
ceeded to examine the func-
tional capacity of genetically
marked cells and investi-gated whether such cells isolated from
the spleen of mouse embryos would sup-
port the formation of artificial lymphoid
tissue. This was tested by embedding
the purified cell population into a biode-
gradable matrix followed by transplanta-
tion of the composites under the kidney
capsule of nontransgenic mice. Strikingly,
under these artificial circumstances,
normal lymphoid structures developed in
which the stromal cells were derived
from the genetically marked input cells.
This finding not only demonstrated the
multipotency of stromal cells but also indi-
cated that the stromal cells carrying the
Nkx2.5 expression mark also contained
a special cell type, the so-called lymphoid
tissue organizer cells (LTo) (Koning and
Mebius, 2012). During development,
these cells initiate the formation of orga-
nized lymphoid tissues and are known to
express a characteristic combination of
cell surface molecules, chemokines, and
cytokines. As expected, the authors’
expression profiling of genetically marked
cells was compatible with this phenotype.
Hence, it appears that Nkx2.5+/Isl1+ mul-
tipotent stromal precursors not only give
rise to the heterogeneous microenviron-
ment of the spleen, but are also capable
of initiating the formation of secondary
lymphoid tissue. However, because Cas-502 Cell Stem Cell 12, May 2, 2013 ª2013 Eltagnaro et al. examined the functional ca-
pacity of a population of cells rather than
that of single cells, they cannot discern
whether LTo cells and multipotent pro-
genitors are different cell types or not.
Castagnaro et al. made the intriguing
observation that Nkx2.5+ cells, which
give rise to the splenic stroma, do not
contribute to other secondary lymphoid
structures such as mesenteric lymph no-
des and Peyer’s patches. This is unex-
pected, because their histological struc-
tures are very similar to that of the
spleen (Mueller and Germain, 2009).
Does this mean that the LTo cells of gut-
associated lymphoid tissues have a
distinct embryological origin? The hy-
pothesis of distinct progenitors of LTo
cells is supported by the observation
that the LTo cells of peripheral lymph
nodes are descendants of adipocytes
(Be´ne´zech et al., 2012). A process of
convergent evolution might thus have
imposed a similar genetic program (LTo
function) on embryologically distinct
types of mesenchymal cells. Such func-
tional plasticity probably also underlies
the generation of so-called tertiary
lymphoid tissue as a result of chronic
inflammation (Neyt et al., 2012).
The study of Castagnaro et al. also
addressed the possible regenerativesevier Inc.capacity of the genetically
marked cells in the splenic
stroma. During the course of
certain viral infections (here
exemplified by lympho-
cytic choriomeningitis virus
[LCMV]), cytopathic effects
lead to the destruction of the
normal architecture of the
spleen’s reticular network
and cause the rapid demise
of stromal cells. Yet, when
the infection is cleared, the
cytoarchitecture of the spleen
is rapidly restored. The au-
thors used this paradigm
to assess whether Nkx2.5+
mesenchymal cells are also
capable of regenerating the
stromal compartment after
viral injury. This is indeed the
case, suggesting that the
same type of multipotent stro-
mal progenitor that gives rise
to the splenic microenviron-
ment during embryonic de-
velopment also functionsduring regeneration in adult animals. This
exciting finding raises intriguing ques-
tions. What is the precise phenotype of
these progenitors and what defines their
niche in the adult spleen? Do similar pro-
genitors also exist in other secondary
lymphoid organs such as lymph nodes?
Are these progenitors capable of self-
renewal? Are they activated simply as a
result of stromal cell loss or, perhaps
more likely, in response to an inflamma-
tory milieu?
The successful isolation of multipotent
stromal progenitors described by Castag-
naro et al. is a welcome boost for efforts
aimed at generating artificial secondary
lymphoid tissues (Kobayashi et al.,
2011). Using this model, it should soon
become possible to identify the signal or
signals that direct their differentiation
into various subsets and to examine
whether these signals are the same for
all secondary lymphoid organs or whether
organ-specific adaptations need to be
taken into account.REFERENCES
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Generating patient-specific oligodendrocyte progenitors capable of repairing myelination defects observed
in multiple neurological afflictions holds great therapeutic potential. Recently in Nature Biotechnology, Najm
et al. (2013) and Yang et al. (2013) generated these progenitors by direct reprogramming, bringing us closer to
their use in disease analysis and autologous transplantation strategies.The progenitor cells that give rise to
myelin-forming oligodendrocytes of the
central nervous system (CNS), referred
to as oligodendrocyte/type-2 astrocyte
progenitor cells and oligodendrocyte pre-
cursor cells (and here abbreviated as
O-2A/OPCs) have been of great interest
in tissue repair for over 20 years. The initial
demonstration, in 1993, that it was
possible to purify O-2A/OPCs from the
developing rat CNS, expand them exten-
sively in vitro using specific combinations
of mitogens, and then use these cells to
repair demyelinating damage in the spinal
cord (Groves et al., 1993) initiated a multi-
laboratory search for means of devel-
oping these approaches for therapeutic
purposes. Achieving such a goal is partic-
ularly important due to the great range of
neurological afflictions in which myelina-
tion abnormalities occur. Such afflictions
include essentially all traumatic CNS in-
juries (including perinatal birth injuries,
stroke, spinal cord injury, and traumatic
brain injury), a wide range of genetic
leukodystrophies, multiple chronic de-
generative disorders (including multiple
sclerosis, Alzheimer’s disease, and
Parkinson’s disease), affective and neuro-
cognitive disorders (including schizo-
phrenia, depression, and autism), andconsequences of systemic exposure to
multiple chemotherapeutic agents and
environmental toxicants.
The path to myelin repair has included
notable successes in isolating multiple
human cell populations able to generate
oligodendrocytes in genetically hypo-
myelinated shiverer mice, which do not
generate compact myelin due to a muta-
tion in myelin basic protein. Such sources
include human neuroepithelial stem cells,
glial precursor cells isolated from human
embryonic stem cells, and fetal glial pre-
cursor cells isolated from the embryonic
CNS. However, cells derived from these
sources will require coordinate use of
immunosuppressive agents, thus leading
to a need to use reprogramming strate-
gies to enable generation of patient-
specific precursor cells, either through
the generation of induced pluripotent
stem cells (Wang et al., 2013) or through
direct reprogramming to the oligodendro-
cyte lineage.
Direct generation of oligodendrocyte
precursors from autologous cells by
direct reprogramming is a critical next
step in the development of myelination
repair strategies, and two papers in
Nature Biotechnology (Najm et al., 2013;
Yang et al., 2013) bring us much closerto achieving this goal. Two multilabora-
tory teams have used mouse and rat em-
bryonic fibroblasts to directly generate
precursor cells able to mature into oligo-
dendrocytes using combinations of
three transcription factors. In both cases,
induced oligodendrocyte precursors
(iOPs) expressed antigens that are also
expressed by O-2A/OPCs, displayed
similar morphologies and responded to
appropriate mitogens, and showed
appropriate global transcriptional re-
modeling indicative of oligodendrocyte
precursors. The iOPs were induced to
differentiate into oligodendrocytes by
exposure to thyroid hormone or with-
drawal of mitogens and exhibited appro-
priate morphologies and patterns of
antigen expression in vitro. Moreover,
iOPs were able to generate myelin-form-
ing oligodendrocytes when transplanted
into the shiverer mouse CNS.
While the studies converged on two
of the three transcriptional regulators
needed to generate iOPs, they differed
in the cocktail’s third component. Specif-
ically, Olig2 and Sox10, both of which
were previously known to be essential
for oligodendrocyte generation (see
Dugas et al., 2006 and references therein)
were present in both transcription factorll 12, May 2, 2013 ª2013 Elsevier Inc. 503
